3-iodobenzylguanidine has been researched along with a-Synucleinopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanakawa, T; Hatano, K; Hatano, T; Hattori, N; Hayashi, T; Ikenaka, K; Ikeuchi, T; Inoue, Y; Iwaki, H; Kadotani, H; Kajiyama, Y; Kamei, Y; Kawabata, K; Matsuda, H; Mochizuki, H; Mukai, Y; Murata, M; Nakamura, T; Nishikawa, N; Saitoh, Y; Sakamoto, T; Sawamoto, N; Shimo, Y; Sumi, Y; Tachimori, H; Takahashi, R; Takahashi, Y; Taruno, Y; Watanabe, H | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and a-Synucleinopathies
| Article | Year |
|---|---|
Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.
Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Biomarkers; Cross-Sectional Studies; Dopamine Plasma Membrane Transport Proteins; Humans; Japan; Parkinson Disease; Prospective Studies; REM Sleep Behavior Disorder; Synucleinopathies | 2022 |